<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02741063</url>
  </required_header>
  <id_info>
    <org_study_id>UESTC-neuSCAN-19</org_study_id>
    <nct_id>NCT02741063</nct_id>
  </id_info>
  <brief_title>Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Electronic Science and Technology of China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Electronic Science and Technology of China</source>
  <brief_summary>
    <textblock>
      to investigate whether oxytocin alter attentional bias towards emotional expression faces in
      individuals with high and low autistic traits, and the brain mechanism of this effect
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the present study, investigator plan to use a double-blind, between-subject placebo
      controlled design.Firstly, all healthy male subjects' autistic trait levels will be assessed
      by the Autism Spectrum Quotient (ASQ) and only subjects with higher or lower ASQ score will
      be recruited in the next experiment and divided into high and low subgroup. Then, subjects
      are randomly assigned to receive either intranasal administration of oxytocin (24 IU) or
      placebo. 45 min later, subject need to complete an attentional bias task named rapid serial
      visual presentation (RSVP) task in fMRI scanner.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>attentional bias toward emotional expression faces</measure>
    <time_frame>1 hour</time_frame>
    <description>attentional bias was measured by the accuracy of each emotional faces in the RSVP task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>brain activity during RSVP task</measure>
    <time_frame>1 hour</time_frame>
    <description>brain activity was measured by the fMRI scanner</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>high autistic and oxytocin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subject with high ASQ scores will receive oxytocin treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low autistic and oxytocin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subject with low ASQ scores will receive oxytocin treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high autistic and placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>subject with high ASQ scores will receive placebo treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low autistic and placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>subject with low ASQ scores will receive placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>screen low autistic subjects</intervention_name>
    <description>screen subjects with low ASQ score</description>
    <arm_group_label>low autistic and oxytocin group</arm_group_label>
    <arm_group_label>low autistic and placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>screen high autistic subjects</intervention_name>
    <description>screen subjects with high ASQ score</description>
    <arm_group_label>high autistic and oxytocin group</arm_group_label>
    <arm_group_label>high autistic and placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oxytocin</intervention_name>
    <description>intranasal administration of oxytocin (24 IU)</description>
    <arm_group_label>high autistic and oxytocin group</arm_group_label>
    <arm_group_label>low autistic and oxytocin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>intranasal administration of placebo (24 IU)</description>
    <arm_group_label>high autistic and placebo group</arm_group_label>
    <arm_group_label>low autistic and placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects without past or current psychiatric or neurological disorders

        Exclusion Criteria:

          -  history of head injury;

          -  claustrophobia;

          -  medical or psychiatric illness.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Kendrick, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Electronic Science and Technology of China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Keith Kendrick, Dr.</last_name>
    <email>k.kendrick.uestc@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>China, Sichuan</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>611731</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Xu</last_name>
      <email>gracetsui.uestc@outlook.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Electronic Science and Technology of China</investigator_affiliation>
    <investigator_full_name>Keith Kendrick</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>oxytocin</keyword>
  <keyword>attentional bias</keyword>
  <keyword>Autism</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

